CE mark of approval given to femtosecond laser platform

Article

The VICTUS femtosecond laser platform has received the CE mark of approval.

The VICTUS femtosecond laser platform has received the CE mark of approval.

Bausch + Lomb collaborated with Technolas Perfect Vision to secure the CE mark approval. The VICTUS laser platform is currently approved for LASIK flap, astigmatic keratotomy, INTRACOR, capsulotomy and lens fragmentation.

The two companies will globally promote VICTUS using their combined commercial skills and cataract and refractive expertise.

Dr Kristian Hohla, CEO of Technolas Perfect Vision, explained, "Our focus has been to empower ophthalmic surgeons with the latest advances in laser technology in order to potentially provide patients with better outcomes and quality of life. We are very pleased that, together with Bausch + Lomb, we have demonstrated the viability of the VICTUS platform for enhances cataract surgery."

President and CEO of Global Surgical Business for Bausch + Lomb, Robert E. Grant, said, "This CE mark approval represents a major step for femtosecond laser technology by elevating the role that laser technology can play in refractive and cataract procedures. I am excited that we will begin shipping this product by the end of next year."

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.